期刊
ALLERGY
卷 73, 期 1, 页码 29-36出版社
WILEY
DOI: 10.1111/all.13239
关键词
atopic dermatitis; interleukin-31; interleukin-31 receptor; pruritus; T helper 2
资金
- Leading Advanced Projects for Medical Innovation
- Research on Development of New Drugs from Japan Agency for Medical Research and Development (AMED)
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (T(H)2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from T(H)2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据